Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| Aug 19 | REGN | Regeneron Pharmaceuticals,… | MEXER | 12,282 | $381.92 | $4.7M | +37.1% | Open the original filing on SEC.gov |
| Dec 8, 2025 | REGN | Regeneron Pharmaceuticals,… | FTAX | 1,396 | $712.94 | $995.3K | -4.5% | Open the original filing on SEC.gov |
| Dec 5, 2025 | REGN | Regeneron Pharmaceuticals,… | AGRANT◆ | 12,210 | — | — | — | Open the original filing on SEC.gov |
| Dec 5, 2025 | REGN | Regeneron Pharmaceuticals,… | AGRANT | 2,476 | — | — | +8.7% | Open the original filing on SEC.gov |
| Nov 20, 2025 | REGN | Regeneron Pharmaceuticals,… | MEXER◆ | 14,450 | — | — | — | Open the original filing on SEC.gov |
| Nov 20, 2025 | REGN | Regeneron Pharmaceuticals,… | FTAX | 12,686 | $736.77 | $9.3M | -35.7% | Open the original filing on SEC.gov |
| Nov 20, 2025 | REGN | Regeneron Pharmaceuticals,… | MEXER | 14,450 | $555.67 | $8M | +68.6% | Open the original filing on SEC.gov |